Literature DB >> 31753130

Epidemiology of aging and associated cognitive disorders: Prevalence and incidence of Alzheimer's disease and other dementias.

Oscar L Lopez1, Lewis H Kuller2.   

Abstract

The study of the incidence and prevalence of dementia is important to understand the distribution of dementing illness among age and sex groups, and for the detection of possible causes of these disorders. A variation in the incidence or prevalence of dementia, especially Alzheimer's disease (AD) by region or specific populations can be because of greater or lesser exposure to the causal agents of dementia. For example, in the past the striking differences in the incidence of coronary heart disease (CHD) led to the understanding of the relationship between dietary factors, such as saturated fat and dietary cholesterol, and the incidence of CHD. However, there is a high prevalence of dementia in elderly individuals around the world, and multiple studies conducted in industrialized and nonindustrialized countries have shown an age-standardized prevalence of dementia ranging from 5% to 7% in most countries. Dementia is not a specific disease but rather a constellation of cognitive changes and disability due to several "causes," i.e., AD, Lewy bodies, vascular disease, drugs, and alcohol. Whether there is a trend for reduced incidence of dementia has to be further evaluated. It is possible that the improvement in the treatments of risk factors, especially vascular disease, has resulted in decreased incidence. However, this could result in an increase in prevalence, since the improved therapies for risk factors will lead to increased longevity in patients with dementia.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Dementia; Incidence; Prevalence

Mesh:

Year:  2019        PMID: 31753130     DOI: 10.1016/B978-0-12-804766-8.00009-1

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  18 in total

1.  Trends in the public health significance, definitions of disease, and implications for prevention of Alzheimer's disease.

Authors:  Carol A Derby
Journal:  Curr Epidemiol Rep       Date:  2020-04-25

Review 2.  Late-onset epilepsy and the risk of dementia: a systematic review and meta-analysis.

Authors:  Lei Huang; Chi Fu; Jie Li; Shijun Peng
Journal:  Aging Clin Exp Res       Date:  2022-04-15       Impact factor: 4.481

Review 3.  On the Common Journey of Neural Cells through Ischemic Brain Injury and Alzheimer's Disease.

Authors:  Jan Kriska; Zuzana Hermanova; Tomas Knotek; Jana Tureckova; Miroslava Anderova
Journal:  Int J Mol Sci       Date:  2021-09-07       Impact factor: 6.208

4.  Fine Particle Exposure and Clinical Aggravation in Neurodegenerative Diseases in New York State.

Authors:  Yanelli Nunez; Amelia K Boehme; Marc G Weisskopf; Diane B Re; Ana Navas-Acien; Aaron van Donkelaar; Randall V Martin; Marianthi-Anna Kioumourtzoglou
Journal:  Environ Health Perspect       Date:  2021-02-08       Impact factor: 9.031

Review 5.  Natural Compounds as Inhibitors of Aβ Peptide Aggregation: Chemical Requirements and Molecular Mechanisms.

Authors:  Katiuscia Pagano; Simona Tomaselli; Henriette Molinari; Laura Ragona
Journal:  Front Neurosci       Date:  2020-12-22       Impact factor: 4.677

6.  Do Personality Traits Influence the Association Between Depression and Dementia in Old Age?

Authors:  Adeleye A Adaralegbe; Henry Egbuchiem; Oluwatomi Adeoti; Khuzeman Abbasi; Esther Ezeani; Ngozi Jane-Frances Adaralegbe; Abdulraheem Olaide Babarinde; Maureen Boms; Chidiebube Nzeako; Olumide Ayeni
Journal:  Gerontol Geriatr Med       Date:  2022-01-12

Review 7.  Nursing procedures for advanced dementia: Traditional techniques versus autonomous robotic applications (Review).

Authors:  Liliana David; Stefan L Popa; Maria Barsan; Lucian Muresan; Abdulrahman Ismaiel; Luminita C Popa; Lacramioara Perju-Dumbrava; Mihaela Fadgyas Stanculete; Dan L Dumitrascu
Journal:  Exp Ther Med       Date:  2021-12-07       Impact factor: 2.447

Review 8.  Critical review of the Withania somnifera (L.) Dunal: ethnobotany, pharmacological efficacy, and commercialization significance in Africa.

Authors:  Henok Kessete Afewerky; Ayeni Emmanuel Ayodeji; Bashir Bolaji Tiamiyu; Joshua Iseoluwa Orege; Emmanuel Sunday Okeke; Aanuoluwapo Opeyemi Oyejobi; Petuel Ndip Ndip Bate; Sherif Babatunde Adeyemi
Journal:  Bull Natl Res Cent       Date:  2021-10-21

9.  Functional Brain Connectivity in Mild Cognitive Impairment With Sleep Disorders: A Study Based on Resting-State Functional Magnetic Resonance Imaging.

Authors:  Yuxi Luo; Mengyuan Qiao; Yuqing Liang; Chongli Chen; Lichuan Zeng; Lin Wang; Wenbin Wu
Journal:  Front Aging Neurosci       Date:  2022-03-10       Impact factor: 5.750

10.  The Cardiac Dysfunction Caused by Metabolic Alterations in Alzheimer's Disease.

Authors:  Jiayuan Murphy; Tran Ngoc Van Le; Julia Fedorova; Yi Yang; Meredith Krause-Hauch; Kayla Davitt; Linda Ines Zoungrana; Mohammad Kasim Fatmi; Edward J Lesnefsky; Ji Li; Di Ren
Journal:  Front Cardiovasc Med       Date:  2022-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.